Risks associated with drug treatments for kidney stones

Nadya E. York, Michael S. Borofsky, James E. Lingeman

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone formation.Areas covered: Herein, we review the most common drugs used in the treatment of renal stones, explaining the mechanism of action and potential side effects. Search of the Medline databases and relevant textbooks was conducted to obtain the relevant information. Further details were sourced from drug prescribing manuals. Recent studies of drug effectiveness are included as appropriate.Expert opinion: Recent controversies include medical expulsive therapy trials and complex role of urinary citrate in stone disease. Future directions in research will involve new medical therapies for stone prevention, for example new drugs for hyperoxaluria.

Original languageEnglish (US)
Pages (from-to)1865-1877
Number of pages13
JournalExpert Opinion on Drug Safety
Volume14
Issue number12
DOIs
StatePublished - Dec 2 2015

Fingerprint

Kidney Calculi
Pharmaceutical Preparations
Hyperoxaluria
Kidney
Drug Prescriptions
Textbooks
Expert Testimony
Citric Acid
Action Potentials
Therapeutics
Databases
Drug Therapy
Research

Keywords

  • adrenergic alpha-Antagonists
  • analgesics
  • anti-inflammatory agents non-steroidal
  • bicarbonates
  • drug therapy
  • kidney calculi
  • renal colic
  • thiazides

Cite this

Risks associated with drug treatments for kidney stones. / York, Nadya E.; Borofsky, Michael S.; Lingeman, James E.

In: Expert Opinion on Drug Safety, Vol. 14, No. 12, 02.12.2015, p. 1865-1877.

Research output: Contribution to journalReview article

York, Nadya E. ; Borofsky, Michael S. ; Lingeman, James E. / Risks associated with drug treatments for kidney stones. In: Expert Opinion on Drug Safety. 2015 ; Vol. 14, No. 12. pp. 1865-1877.
@article{6543ea23d68a488ea20f7450150b2a9c,
title = "Risks associated with drug treatments for kidney stones",
abstract = "Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone formation.Areas covered: Herein, we review the most common drugs used in the treatment of renal stones, explaining the mechanism of action and potential side effects. Search of the Medline databases and relevant textbooks was conducted to obtain the relevant information. Further details were sourced from drug prescribing manuals. Recent studies of drug effectiveness are included as appropriate.Expert opinion: Recent controversies include medical expulsive therapy trials and complex role of urinary citrate in stone disease. Future directions in research will involve new medical therapies for stone prevention, for example new drugs for hyperoxaluria.",
keywords = "adrenergic alpha-Antagonists, analgesics, anti-inflammatory agents non-steroidal, bicarbonates, drug therapy, kidney calculi, renal colic, thiazides",
author = "York, {Nadya E.} and Borofsky, {Michael S.} and Lingeman, {James E.}",
year = "2015",
month = "12",
day = "2",
doi = "10.1517/14740338.2015.1100604",
language = "English (US)",
volume = "14",
pages = "1865--1877",
journal = "Expert Opinion on Drug Safety",
issn = "1474-0338",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Risks associated with drug treatments for kidney stones

AU - York, Nadya E.

AU - Borofsky, Michael S.

AU - Lingeman, James E.

PY - 2015/12/2

Y1 - 2015/12/2

N2 - Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone formation.Areas covered: Herein, we review the most common drugs used in the treatment of renal stones, explaining the mechanism of action and potential side effects. Search of the Medline databases and relevant textbooks was conducted to obtain the relevant information. Further details were sourced from drug prescribing manuals. Recent studies of drug effectiveness are included as appropriate.Expert opinion: Recent controversies include medical expulsive therapy trials and complex role of urinary citrate in stone disease. Future directions in research will involve new medical therapies for stone prevention, for example new drugs for hyperoxaluria.

AB - Introduction: Renal stones are one of the most painful medical conditions patients experience. For many they are also a recurrent problem. Fortunately, there are a number of drug therapies available to treat symptoms as well as prevent future stone formation.Areas covered: Herein, we review the most common drugs used in the treatment of renal stones, explaining the mechanism of action and potential side effects. Search of the Medline databases and relevant textbooks was conducted to obtain the relevant information. Further details were sourced from drug prescribing manuals. Recent studies of drug effectiveness are included as appropriate.Expert opinion: Recent controversies include medical expulsive therapy trials and complex role of urinary citrate in stone disease. Future directions in research will involve new medical therapies for stone prevention, for example new drugs for hyperoxaluria.

KW - adrenergic alpha-Antagonists

KW - analgesics

KW - anti-inflammatory agents non-steroidal

KW - bicarbonates

KW - drug therapy

KW - kidney calculi

KW - renal colic

KW - thiazides

UR - http://www.scopus.com/inward/record.url?scp=84951905299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951905299&partnerID=8YFLogxK

U2 - 10.1517/14740338.2015.1100604

DO - 10.1517/14740338.2015.1100604

M3 - Review article

VL - 14

SP - 1865

EP - 1877

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

SN - 1474-0338

IS - 12

ER -